T.J. Karpanen
University Hospitals Birmingham NHS Foundation Trust
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by T.J. Karpanen.
Journal of Antimicrobial Chemotherapy | 2011
T.J. Karpanen; A.L. Casey; Barbara R. Conway; Peter A. Lambert; Tom Elliott
OBJECTIVES The antimicrobial efficacy of a chlorhexidine gluconate (CHG) intravascular catheter gel dressing was evaluated against methicillin-resistant Staphylococcus aureus (MRSA) and an extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. Chlorhexidine deposition on the skin surface and release from the gel were determined. METHODS The antimicrobial efficacy was evaluated in in vitro studies following microbial inoculation of the dressing and application of the dressing on the inoculated surface of a silicone membrane and donor skin [with and without a catheter segment and/or 10% (v/v) serum] on diffusion cells. Antimicrobial activity was evaluated for up to 7 days. Chlorhexidine skin surface deposition and release were also determined. RESULTS MRSA and E. coli were not detectable within 5 min following direct inoculation onto the CHG gel dressing. On the silicone membrane, 3 log and 6 log inocula of MRSA were eradicated within 5 min and 1 h, respectively. Time to kill was prolonged in the presence of serum and a catheter segment. Following inoculation of donor skin with 6 log cfu of MRSA, none was detected after 24 h. Chlorhexidine was released from the gel after a lag time of 30 min and increasing amounts were detected on the donor skin surface over the 48 h test period. The CHG gel dressing retained its antimicrobial activity on the artificial skin for 7 days. CONCLUSIONS The CHG intravascular catheter site gel dressing had detectable antimicrobial activity for up to 7 days, which should suppress bacterial growth on the skin at the catheter insertion site, thereby reducing the risk of infection.
Journal of Antimicrobial Chemotherapy | 2015
A.L. Casey; T.J. Karpanen; Peter Nightingale; Barbara R. Conway; Tom Elliott
OBJECTIVES The antimicrobial efficacy of an iodine-impregnated incise drape against MRSA was evaluated in a skin model. The permeation of iodine from this drape into the skin was also assessed. METHODS The antimicrobial efficacy was evaluated in ex vivo studies following application of the surgical incise drape for various times on the surface of donor skin, which was inoculated with either 1 × 10(3) or 1 × 10(6) cfu MRSA/cm(2) skin and mounted on Franz diffusion cells. In some experiments the MRSA-inoculated skin was pre-incubated for 18 h at room temperature prior to applying the drape. Permeation of iodine into the skin using this model was also determined following application of the incise drape for 6 h. RESULTS The iodine-impregnated drape demonstrated antimicrobial activity compared with the non-use of drape. This reached significance when a high inoculum of MRSA was applied with no pre-incubation period and when a low inoculum of MRSA was applied with a pre-incubation period (P = 0.002 and P = 0.014, respectively). Furthermore, in experiments wherein a high inoculum of MRSA was applied with no pre-incubation period, the iodine-impregnated drape demonstrated superior antimicrobial activity compared with the use of a non-antimicrobial drape (P < 0.001). MIC and MBC values of iodine were attained to 1500 μm below the skin surface. CONCLUSIONS The iodine-impregnated surgical incise drape had detectable antimicrobial activity. Furthermore, iodine penetrated into the deeper layers of the skin. This property should suppress microbial regrowth at and around a surgical incision site, making its use preferable to the use of a standard drape or non-use of a drape.
British journal of nursing | 2018
A.L. Casey; T.J. Karpanen; Peter Nightingale; Tom Elliott
BACKGROUND needle-free connectors are widely used in clinical practice. The aim of this study was to identify any differences between microbial ingress into six different connectors (three neutral-displacement, one negative-displacement and two anti-reflux connectors). METHODS each connector underwent a 7-day clinical simulation involving repeated microbial contamination of the connectors injection ports with Staphylococcus aureus followed by decontamination and then saline flushes through each connector. The simulation was designed to be a surrogate marker for the potential risk of contamination in clinical practice. RESULTS increasing numbers of S. aureus were detected in the flushes over the 7 days of sampling despite adherence to a rigorous decontamination programme. Significant differences in the number of S. aureus recovered from the saline flush of some types of connectors were also detected. Two different durations (5- and 15-second) of decontamination of the injection ports with 70% isopropyl alcohol (IPA) wipes were also investigated. There was no significant difference between the median number of S. aureus recovered in the saline flushes following a 5-second (165.5, 95% CI=93-260) or a 15-second decontamination regimen (75, 10-190). CONCLUSIONS The findings suggest that there may be differences in the risk of internal microbial contamination with different types of connectors and that even 15 seconds of decontamination may not fully eradicate microorganisms from the injection ports of some devices.
Antimicrobial Resistance and Infection Control | 2018
A.L. Casey; T.J. Karpanen; Peter Nightingale; Tom Elliott
BackgroundThe optimal decontamination method for needle-free connectors is still unresolved. The objective of this study was to determine if a continuous passive disinfection cap is as effective as standard cleaning for the microbial decontamination of injection ports of two types of needle-free connectors.MethodsThe injection ports of needle-free connectors were inoculated with Staphylococcus aureus and allowed to dry. Disinfection caps containing 70% (v/v) isopropyl alcohol (IPA) were attached to the connectors for one, three or 7 days and were compared with needle-free connectors cleaned with 2% (w/v) chlorhexidine gluconate (CHG) in 70% (v/v) IPA. The number of S. aureus remaining on the injection ports was evaluated. Median log10 reductions and 95% confidence interval (CI) were calculated and data analyzed using the Mann-Whitney test.ResultsThe application of the disinfection cap resulted in a significantly higher reduction in S. aureus than the 2% (w/v) CHG in 70% (v/v) IPA wipe, achieving a > 5 Log10 reduction in CFU at each time point.ConclusionsThe disinfection caps resulted in a significantly higher reduction in S.aureus on the injection ports when compared to the use of a 2% (w/v) CHG in 70% (v/v) IPA wipe. This offers an explanation for the lower rates of central-line associated bloodstream infection (CLABSI) associated with the use of disinfection caps reported in clinical studies.
Antimicrobial Resistance and Infection Control | 2015
T.J. Karpanen; A.L. Casey; Tony Whitehouse; Peter Nightingale; Ira Das; Tom Elliott
Although infection risk associated with central venous catheters (CVC) has reduced in recent years, the use of CVC are still associated with relatively large number of infections, leading to increased patient morbidity and healthcare costs. A major source of microbial colonisation and infection of short term CVC is the patients’ endogenous skin microorganisms located at the catheter insertion site.
Journal of Hospital Infection | 2010
A.L. Casey; D. Adams; T.J. Karpanen; Peter A. Lambert; Barry Cookson; Peter Nightingale; L. Miruszenko; R. Shillam; P. Christian; Tom Elliott
Journal of Hospital Infection | 2012
A.L. Casey; T.J. Karpanen; Peter Nightingale; M. Cook; Tom Elliott
BMC Infectious Diseases | 2017
A.L. Casey; T.J. Karpanen; Barbara R. Conway; Tony Worthington; Peter Nightingale; R. Waters; Tom Elliott
The Journal of the Association for Vascular Access | 2016
T.J. Karpanen; A.L. Casey; Ira Das; Tony Whitehouse; Peter Nightingale; Tom Elliott
Archive | 2010
T.J. Karpanen; E.R. Hendry; Tony Worthington; Peter A. Lambert; Barbara R Conway